Nuvectis Pharma NVCT
NASDAQ NVCT
$21.48 +0.76 (+3.66%)
As of: Oct 2, 2026 · 10:29 AM EDT

Nuvectis Pharma (NVCT) Return on Assets [ROA] (2022 - 2026)

Updated

Nuvectis Pharma's Return on Assets [ROA] came in at -116.57% for Q2 2026, down 39.36 percentage points from -77.22% a year earlier and down 21.45 percentage points from the prior quarter.

Analysis

Nuvectis Pharma (NVCT) Return on Assets [ROA] (2022 - 2026) Analysis & Trends

For FY2025, Nuvectis Pharma's Return on Assets [ROA] was -105.10%, down 4.55 percentage points from FY2024.

  • Return on Assets [ROA] carries a three-year change of +35.94 percentage points (FY2022 to FY2025).
  • Going back by year, Return on Assets [ROA] was -100.55% in FY2024 (+11.90 pp), -112.45% in FY2023 (+28.59 pp) and -141.05% in FY2022.
  • The Q2 2026 figure represents the lowest quarterly Return on Assets [ROA] since Q1 2022.
  • Year-over-year, Return on Assets [ROA] increased in five of the last eight quarters, with an average year-over-year change of +7.10 percentage points.
  • The fastest year-over-year change in Return on Assets [ROA] over five years came in Q2 2025 (a gain of 33.81 percentage points), and the weakest in Q2 2026 (a drop of 39.36 percentage points).
  • Business Quant data shows NVCT's Return on Assets [ROA] at -95.12% (Q1 2026), -78.58% (Q4 2025) and -81.08% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Nuvectis Pharma 563.79 Mn 563.79 Mn - -116.57%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -116.57%
Mar 31, 2026 -95.12%
Dec 31, 2025 -78.58%
Sep 30, 2025 -81.08%
Jun 30, 2025 -77.22%
Mar 31, 2025 -82.70%
Dec 31, 2024 -105.81%
Sep 30, 2024 -108.83%
Jun 30, 2024 -111.03%
Mar 31, 2024 -115.08%
Dec 31, 2023 -107.41%
Sep 30, 2023 -94.63%
Jun 30, 2023 -108.53%
Mar 31, 2023 -110.29%
Dec 31, 2022 -84.31%
Sep 30, 2022 -74.95%
Jun 30, 2022 -84.41%
Mar 31, 2022 -130.29%
API Access

Nuvectis Pharma Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NVCT&period=max&api_key=YOUR_API_KEY